Serum Free Light Chain Quantitative Assays: Dilemma of a Biomarker

Journal of Clinical Laboratory Analysis - United States
doi 10.1002/jcla.22243
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Increased Serum Free Light Chains Precede the Presentation of Immunoglobulin Light Chain Amyloidosis

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Diagnosis and Monitoring for Light Chain Only and Oligosecretory Myeloma Using Serum Free Light Chain Tests

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2017English

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis

Frontiers in Neurology
Neurology
2019English

Evaluation of the Impact of Renal Failure on Correlation and Concordance Between 2 Free Light Chain Assays

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2016English

Serum Free Immunoglobulin Light Chain Evaluation as a Marker of Impact From Intraclonal Heterogeneity on Myeloma Outcome

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Effectiveness of Heavy-Light Chain Quantitative Test: A Systematic Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

The Use of Serum Free Light Chain Dimerization Patterns Assist in the Diagnosis of AL Amyloidosis

British Journal of Haematology
Hematology
2018English

Prognostic Utility of Serum Free Light Chain Ratios and Heavy-Light Chain Ratios in Multiple Myeloma in Three PETHEMA/GEM Phase III Clinical Trials

PLoS ONE
Multidisciplinary
2018English

Interference-Free HER2 ECD as a Serum Biomarker in Breast Cancer

Journal of Molecular Biomarkers & Diagnosis
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy